Takeda Fellowships

Takeda Pharmaceuticals, in collaboration with MCPHS, offers unique fellowships to promote the role of the Doctor of Pharmacy (PharmD) within the biopharmaceutical industry. Fellows gain extensive experience through various practical activities in both industry and academic settings, which will enhance the potential for accelerated career development. The following options are offered by Takeda in conjunction with MCPHS:

  • Global Medical Information and Review, Oncology (1 year) - recruiting for 2 positions
  • Global Scientific Communications, Oncology (Not recruiting for 2023-2024)
  • Global Pharmacovigilance (2 years) (Not recruiting for 2023-2024)
  • Global Clinical Supply Chain - recruiting for 1 position

Please see our brochure for additional details.

About Takeda Pharmaceuticals

Founded in 1781, Takeda is a patient-focused, values-based, research and development (R&D)-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide. Our passion and pursuit of potentially life-changing treatments for patients are deeply rooted in our distinguished 240-year history in Japan. At the U.S. headquarters for Takeda, four of our eight global business units and biologics manufacturing site are centered in Massachusetts enabling us to build relationships with cutting-edge companies, academic institutions, scientists and organizations who join us in the effort to discover, develop, and deliver new treatments to patients. We have 20 locations across the greater Boston area. As a R&D-driven organization, Takeda has state-of-the-art facilities to help advance the next generation of innovation. Takeda’s pharmaceutical products are marketed in around 100 countries worldwide, including partnerships (marketing alliance partners). The company has grown in size and scope both organically and through acquisition. Takeda-ism (our values of Integrity, Fairness, Honesty, and Perseverance) grounds us as we deliver on our role to serve the public by ensuring integrity in our every action for and on behalf of patients.

Takeda focuses its R&D efforts on four therapeutic areas: oncology, gastrointestinal and inflammation, rare diseases and neuroscience. We also make targeted R&D investments in plasma-derived therapies and vaccines. For more than 70 years, Takeda has supplied vaccines to protect the health of people in Japan. Today, Takeda’s global vaccine business is applying innovation to tackle some of the world’s most challenging infectious diseases, such as dengue, Zika and norovirus. We are developing highly innovative medicines that contribute to making a difference in people’s lives by advancing the frontier of new treatment options and leveraging our enhanced collaborative R&D engine and capabilities to create a robust, modality-diverse pipeline.